Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amphastar Pharma (NQ: AMPH )

35.35 +0.56 (+1.61%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 408,505
Open 34.75
Bid (Size) 33.00 (1)
Ask (Size) 35.50 (3)
Prev. Close 34.79
Today's Range 34.42 - 35.41
52wk Range 17.56 - 44.46
Shares Outstanding 48,829,793
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Amphastar Pharmaceuticals Stock Scores Composite Rating Climb To 96
Amphastar Pharmaceuticals stock saw its IBD SmartSelect Composite Rating rise to 96 Thursday, up from 94 the day before. 
Via Investor's Business Daily
Kura Oncology Stock Scores Rising Relative Strength
On Thursday, Kura Oncology stock had its Relative Strength (RS) Rating stock upgraded to 93 from 81 a day earlier. 
Via Investor's Business Daily

Performance

YTD
+53.82%
+53.82%
1 Month
-6.13%
-6.13%
3 Month
-5.51%
-5.51%
6 Month
+51.78%
+51.78%
1 Year
+72.95%
+72.95%

More News

Read More
Syndax Pharmaceuticals Stock Sees RS Rating Rise To 92
Via Investor's Business Daily
Amylyx Pharmaceuticals Stock Clears Key Benchmark, Hitting 90-Plus RS Rating
Via Investor's Business Daily
Day One Biopharmaceuticals Stock Scores Rising Relative Strength Upgrade
Via Investor's Business Daily
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Amphastar's Generic Ganirelix Acetate Injection Scores FDA Approval
Via Benzinga
69 Biggest Movers From Yesterday
Via Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Small-Cap Psychedelic Play Vying for Future Leadership in Addiction Treatment (AXSM, AWKNF, BICX, OPNT, ALKS, PFE, AMPH, OMER)
Via AB Newswire
Amphastar Pharmaceuticals's Return On Capital Employed Insights
Via Benzinga
United Therapeutics Stock Sees RS Rating Jump To 89; Earns 'Blue Dot'
Via Investor's Business Daily
Amphastar Receives FDA Approval for Regadenoson
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Exposures Product Safety
7 Safe Small-Cap Stocks to Buy Now
Via InvestorPlace
Intra-Cellular Therapies Stock Clears Technical Benchmark, Hitting 90-Plus RS Rating
Via Investor's Business Daily
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2022
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2022
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Krystal Biotech Stock Sees Healthy Relative Strength Rating Upgrade
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
10 Stocks That Have Moved Over 20% Since The Indices Plummeted
Via Benzinga
Why Top-Rated IBD 50 Stock Amphastar Pharmaceuticals Added To Its 75% Run
Via Investor's Business Daily
Amphastar Receives FDA Approval for Ganirelix Acetate Injection
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Exposures Product Safety
Sarepta Therapeutics Stock Shows Market Leadership With Jump To 85 RS Rating
Via Investor's Business Daily
Supernus Pharmaceuticals Stock Sees Relative Strength Rating Jump To 92
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.